Ebolavirus and Marburgvirus: insight the Filoviridae family.

Keywords

Ebolavirus, Filoviridae, Virology, Biology, Marburg virus

References

• Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins.Antonio Revenga Carbonell — 2001
• Therapy and prophylaxis of Ebola virus infections.Heinz Feldmann, Steven M Jones, Hans‐Joachim Schnittler — 2005
• Apoptosis in fatal Ebola infection. Does the virus toll the bell for immune system?Sylvain Baize, Eric M. Leroy, Elie Mavoungou — 2000
• Reverse genetics of mononegavirales.Karl‐Klaus Conzelmann — 2004
• Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya.E. D. Johnson, Bruce K. Johnson, David M Silverstein — 1996
• Escaping from the cell: assembly and budding of negative-strand RNA viruses.Anthony P. Schmitt, Robert A. Lamb — 2004
• A hitherto unknown infectious disease contracted from monkeys. "Marburg-virus" disease.G. A. Martini, H. G. Knauff, Hans Schmidt — 1968
• The Microbial Rosetta Stone Database: A compilation of global and emerging infectious microorganisms and bioterrorist threat agentsDavid J. Ecker, Rangarajan Sampath, Paul Willett — 2005
• Ebola virus outbreaks in the Ivory Coast and Liberia, 1994-1995.B. Le Guenno, Pierre Formenty, Christophe Boesch — 1999
• Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.Thomas W. Geisbert, Howard A. Young, Peter B. Jahrling — 2003
• Ebola virus: from discovery to vaccineHeinz Feldmann, Steven J.M. Jones, Hans‐Dieter Klenk — 2003
• Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.Aliyu Kane, John Lloyd, Michel Zaffran — 1999
• The biogenesis of multivesicular endosomesJean Grüenberg, Harald Stenmark — 2004
• Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primatesThomas G. Ksiazek, Pierre E. Rollin, Peter B. Jahrling — 1992
• Ebola virus ecology: a continuing mystery.Heinz Feldmann, Victoria Wahl‐Jensen, Steven M. Jones — 2004
• Bats as a continuing source of emerging infections in humansSamson S. Y. Wong, Susanna K. P. Lau, Patrick C. Y. Woo — 2006
• Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution.V.N. Malashkevich, Brian J. Schneider, Margaret L. McNally — 1999
• How Ebola and Marburg viruses battle the immune systemMansour Mohamadzadeh, Lieping Chen, Alan Schmaljohn — 2007
• Isolation and partial characterisation of a new strain of Ebola virus.B. Le Guenno, Pierre Formenty, Monique Wyers — 1995
• Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.Peter Pushko, Mike Bray, George V. Ludwig — 2000

Cited by

• Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Protects Nonhuman Primates from Intramuscular and Aerosol Challenge with Ebolavirus万佑子 安元, 淳 佐々木, 琢麿 石垣 — 2013
• Etude de la modulation de la réponse cellulaire au stress oxydatif par les protéines VP24 des virus Marburg et EbolaA. Page — 2012
• General introduction into the Ebola virus biology and disease.Barbara Zawilińska, Magdalena Kosz‐Vnenchak — 2014
• Properties associated with filoviral-glycoprotein-mediated entry events in permissive cellsCatherine Leta Miller — 2010
• Exploitation of Ebola Virus VP35 Protein to identify new drugs counteracting its type I IFN antagonismV. Cannas — 2015
• Against the clock towards new Ebola virus therapies.Carles Martínez‐Romero, Adolfo Garcı́a-Sastre — 2015
• Prediction of Epitope-Based Peptides for Vaccine Development from Coat Proteins GP2 and VP24 of Ebola Virus Using ImmunoinformaticsPratik Narain Srivastava, Richa Jain, Shyam Dhar Dubey — 2016
• Vesicular stomatitis virus infects resident cells of the central nervous system and induces replication-dependent inflammatory responses.Vinita Chauhan, Samantha R. Furr, David Sterka — 2010
• Ebola Virus-Like Particles Stimulate Type I Interferons and Proinflammatory Cytokine Expression Through the Toll-Like Receptor and Interferon Signaling PathwaysNatarajan Ayithan, Steven B. Bradfute, Scott M. Anthony — 2014
• Ebola and Marburg vaccines for Africa: one step closer.Saranya Sridhar — 2015
• Post-exposure treatment of Ebola virus using passive immunotherapy: proposal for a new strategyJean‐Philippe Chippaux, Leslie Boyer, Alejandro Alagón — 2015
• No exit: targeting the budding process to inhibit filovirus replicationRonald N. Harty — 2008
• Identification of an antioxidant small-molecule with broad-spectrum antiviral activity.Rekha G. Panchal, St. Patrick Reid, Julie P. Tran — 2012
• What is Ebola?Richard A. Stein — 2014
• The Tyro3 Receptor Kinase Axl Enhances Macropinocytosis of Zaire EbolavirusCatherine L. Hunt, Andrey A. Kolokoltsov, Robert A. Davey — 2010
• The Baboon (Papio spp.) as a Model of Human Ebola Virus InfectionDonna L. Perry, Laura Bollinger, Gary L. White — 2012
• Why does size matter for viruses--a new paradigm on viral size.Gnanadurai John Fletcher, Solomon Christopher, Manu Gnanamony — 2009
• Ebola: A holistic approach is required to achieve effective management and controlAnna Roca, Muhammed O. Afolabi, Yauba Saidu — 2015
• The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathwayNirupama Mulherkar, Matthijs Raaben, Juan Carlos de la Torre — 2011
• Cross-platform evaluation of commercial real-time reverse transcription PCR master mix kits using a quantitative 5'nuclease assay for Ebola virus.Kenyatta W. Stephens, Rebecca J. Hutchins, Leslie A. Dauphin — 2010

Related papers

• Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteinsElisabeth K. Nyakatura, Samantha E. Zak, Anna Z. Wec — 2018
• Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus TreatmentSara Landeras-Bueno, Shun-ichiro Oda, Michael Norris — 2019
• The crystal structure of the C-terminal domain of the Ebola virus nucleoproteinZygmunt S. Derewenda, Paulina J. Dziubańska-Kusibab, Urszula Derewenda — 2014
• Marburg and Ebola virusesA. Simpson, E. Aarons, R. Hewson — 2011
• Comprehensive Profiling of Immune Responses in MARV Survivors Demonstrates Robust Th1-Skewing with Short-Lived Neutralizing Antibody ResponsesSpencer W. Stonier, Andrew S. Herbert, Ana I. Kuehne — 2017
• Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.Antonello Pessi, Sandra L. Bixler, Veronica Soloveva — 2019
• Insight into the Ebola virus nucleocapsid assembly mechanism: crystal structure of Ebola virus nucleoprotein core domain at 1.8 Å resolutionShishang Dong, Peng Yang, Guobang Li — 2015
• Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primatesJennifer M. Brannan, Shihua He, Katie A. Howell — 2019
• Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola VirusThomas W. Geisbert, Joan B. Geisbert, Anders Leung — 2009